How Changes In Drug-Safety Regulations Affect The Way Drug And Biotech Companies Invest In Innovation
Author:
Affiliation:
1. Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, in Durham, North Carolina
Publisher
Health Affairs (Project Hope)
Subject
Health Policy
Reference17 articles.
1. Postmarketing Surveillance—Lack of Vigilance, Lack of Trust
2. The Research on Adverse Drug Events and Reports (RADAR) Project
3. Combining Net Present Value and Strategic Attractiveness to Evaluate Drug Development Alternatives
4. The price of innovation: new estimates of drug development costs
5. “Establishment of Prescription Drug User Fee Rates for Fiscal Year 2005,” Federal Register 69 , no. 147 ( 2004 ): 46165 –4 6168 .
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Innovation in Chemistry, Manufacturing, and Controls—A Regulatory Perspective From Industry;Journal of Pharmaceutical Sciences;2019-07
2. Dormancy as a Strategic Response to Detrimental Public Policy;Organization Science;2015-12-30
3. Regulating in developing countries: Multiple roles for medical research and products regulation in Argentina and India;Technology in Society;2015-11
4. Drug Safety and the Cost of Monitoring: The Role of REMS in Risk Management;Therapeutic Innovation & Regulatory Science;2015-07
5. Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies;Pharmacoepidemiology and Drug Safety;2014-01-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3